Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD

Clinical trial NCT07059091 · RECRUITING

Trial details

NCT number: NCT07059091
Sponsor: Johns Hopkins University
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Chronic Obstructive Pulmonary Disease (COPD)Allergies

Start date: 2026-02-12
Primary completion: 2031-01-01
Enrollment: 334

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.